Estimating Racial and Ethnic Disparities in Substance Use Disorder Treatment and Harm Reduction Services: Findings From a Survey of People Who Use Drugs

Gibbons JB, Bandara S, Cook BL, Byrne L, Sugarman OK, Kerins L, Pugh T, Hulsey EG, Heller D, Minna S, Saloner B - Health Services Research

  • Price, Value, and Access

Summary:

In a survey of 1,651 people who use drugs, Black, Hispanic, and American Indian/Alaska Native respondents reported substantially lower use of harm reduction and substance use disorder (SUD) treatment services than White respondents. The authors conclude that conventional adjustment methods in such studies can mask true inequities and recommend Institute of Medicine-aligned approaches to more accurately measure and address health disparities.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access